AFRICANEWSWIRE.NET (April, 30 2012) Recently US Food and Drug Administration approved Omontys, a drug that is indicated for treating anemia due to Chronic Kidney Disease (CKD). Omontys contains the active ingredient peginesatide developed by Affymax Inc. Omontys will be marketed in USA by Affimax Inc. and Takeda Pharmaceutical Company Ltd. FDA has approved the drug on a recommendation in last December, by an advisory panel which voted 15 to 1 in support of the drug. Omontys is the first new FDA-approved and marketed ESA drug for anemic patients under dialysis since 2001.
It is estimated that there are more than 400,000 Kidney patients in USA undergoing dialysis. They get anemic and need to be given blood transfusions or treated with erythropoietin (EPO) to stimulate the production of red blood cells. The new drug Omontys joins the two existing drugs, Epogen and Aranesp that are used to treat anemia in CKD patients. Omontys should be used only for the patients under dialysis and it should not be used for anemia due to causes other than CKD like cancer-related anemia. Anemia in CKD patients leads to cardiovascular illness and mortality.
Anemia is a condition in which the body doesn't have enough healthy red blood cells. In healthy people, kidneys produce a hormone called erythropoietin (EPO) that stimulates the bone marrow to produce red blood cells. In dialysis patients who have chronic kidney disease, kidneys fail to make enough EPO. As a result, the bone marrow makes fewer red blood cells leading to anemia. Omontys stimulates the bone marrow to produce more red blood cells and reduces the need of blood transfusions in patients with chronic kidney disease. Omontys is administered as a once a month injection, hence more convenient than other once a week injections.
A spokesperson for the leading Canada pharmacy, Big Mountain Drugs (BMD) said they welcomed the approval of new drugs and new treatments that help large number of patients. “We keep ourselves alert to the approval processes and strive to bring the new drugs and treatments that are discovered, invented or developed by research scientists and research centers allover the world. We are always on the lookout for new developments and add the new drugs to our portfolio as soon as they are approved by the authorities and introduced to the market. Our prices are very competitive and range from 50% to 80% of the prices at local pharmacies in US.”
Big Mountain Drugs is a Canadian online pharmacy registered and licensed in the Province of British Columbia. It is licensed by College of Pharmacists of British Columbia, the regulating body for pharmacies in the province of British Columbia. In addition to operating regular brick and mortar pharmacies BMD offers its services to worldwide customers through its website Bigmountaindrugs.com. Being a verified member of Canadian International Pharmacy Association (CIPA), Big Mountain Drugs is committed to the legal, ethical, quality, and professional standards of the industry. PharmacyChecker.com an independent company that verifies the international online pharmacies, also has verified Big Mountain Drugs. Customers should satisfy themselves on the credibility of any website they are dealing with, before making a purchase. They can check any online pharmacy from the websites of licensing authorities and verifying organizations, to avoid being victimized by the rogue pharmacies.
Big Mountain Drugs provides a wide portfolio of branded and generic prescription as well as OTC Drugs at affordable prices via its licensed Canada pharmacy. Customers can now Buy Plavix or Generic Plavix and other Canada prescription drugs from BMD and have it delivered worldwide to their doorstep. Big Mountain Drugs is a CIPA approved pharmacy operating from British Colombia, Canada.
For more information on Big Mountain Drugs.Com:
Name : Ms. Estella Wong
Tel : 1.778.218.2670
Web : http://www.bigmountaindrugs.com/
8322 130th Street, Surrey,
British Columbia, Canada, V3W 8J9